Product logins

Find logins to all Clarivate products below.


chevron_left

Oncology Drugs to Watch: ASCO 2025 Highlights

Thought Leadership

Clarivate’s oncology analysts bring you concise, strategic takeaways from this year’s ASCO event – covering key clinical developments, trial readouts, and implications for the future of cancer treatment.

What’s inside the report:

  • Insights on 13 global oncology drugs tracked by Clarivate
  • Late-phase clinical data highlights and trial outcomes
  • Commercial and strategic implications from this year’s ASCO Annual Meeting
  • Analyst perspectives on what’s next for each therapy

Download the report to get the latest insights.

Related insights

The latest news, technologies, and resources from our team.

Six emerging cost/access drivers we’re watching in 2026
Radioligand innovators ushering in a new era of precision oncology Radioligand innovators ushering in a new era of precision oncology
Radioligand innovators ushering in a new era of precision oncology
Benchmarking orthopedic implant prices in ASCs
chevron_left
chevron_right